Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd. - Enterprise Valueverified

EMCURE.NS

Price:

$1851.5

Market Cap:

$351.19B

Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2024-07-10

Stock Exchange

NSE

Ticker

EMCURE.NS

The Enterprise Value as of October 2026 (TTM) for Emcure Pharmaceuticals Ltd. (EMCURE.NS) is 365.04B

According to Emcure Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 365.04B. This represents a change of 155.83% compared to the average of 142.69B of the last 4 quarters.

Emcure Pharmaceuticals Ltd. (EMCURE.NS) Historical Enterprise Value (quarterly & annually)

How has EMCURE.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Emcure Pharmaceuticals Ltd. over the last ten years is 263.30B. The current 365.04B Enterprise Value has changed 13.76% with respect to the historical average. Over the past ten years (40 quarters), EMCURE.NS's Enterprise Value was at its highest in in the March 2026 quarter at 316.38B. The Enterprise Value was at its lowest in in the December 2024 quarter at 0.

Quarterly (TTM)
Annual

Average

263.30B

Median

263.30B

Minimum

210.27B

Maximum

316.33B

Emcure Pharmaceuticals Ltd. (EMCURE.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Emcure Pharmaceuticals Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 50.44%

Maximum Annual Enterprise Value = 316.33B

Minimum Annual Increase = 0%

Minimum Annual Enterprise Value = 210.27B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2026316.33B50.44%

Emcure Pharmaceuticals Ltd. (EMCURE.NS) Average Enterprise Value

How has EMCURE.NS Enterprise Value performed in the past?

The current Enterprise Value of Emcure Pharmaceuticals Ltd. (EMCURE.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

263.30B

5-year avg

263.30B

10-year avg

263.30B

Emcure Pharmaceuticals Ltd. (EMCURE.NS) Enterprise Value vs. Peers

How is EMCURE.NS’s Enterprise Value compared to its peers?

Emcure Pharmaceuticals Ltd.’s Enterprise Value is less than Cipla Limited (1.06T), less than Dr. Reddy's Laboratories Limited (1.04T), less than Aurobindo Pharma Limited (946.50B), less than Lupin Limited (885.62B), less than Alkem Laboratories Limited (627.66B), less than Ipca Laboratories Limited (494.22B), less than Torrent Pharmaceuticals Limited (1.76T), less than Mankind Pharma Limited (982.93B), less than Sun Pharmaceutical Industries Limited (4.22T), less than Glenmark Pharmaceuticals Limited (612.81B),

Build a custom stock screener for Emcure Pharmaceuticals Ltd. (EMCURE.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emcure Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emcure Pharmaceuticals Ltd. (EMCURE.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emcure Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Emcure Pharmaceuticals Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Emcure Pharmaceuticals Ltd. (EMCURE.NS)?

What is the 3-year average Enterprise Value for Emcure Pharmaceuticals Ltd. (EMCURE.NS)?

What is the 5-year average Enterprise Value for Emcure Pharmaceuticals Ltd. (EMCURE.NS)?

How does the current Enterprise Value for Emcure Pharmaceuticals Ltd. (EMCURE.NS) compare to its historical average?